These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 37488222)

  • 1. Deep learning predicts patients outcome and mutations from digitized histology slides in gastrointestinal stromal tumor.
    Fu Y; Karanian M; Perret R; Camara A; Le Loarer F; Jean-Denis M; Hostein I; Michot A; Ducimetiere F; Giraud A; Courreges JB; Courtet K; Laizet Y; Bendjebbar E; Du Terrail JO; Schmauch B; Maussion C; Blay JY; Italiano A; Coindre JM
    NPJ Precis Oncol; 2023 Jul; 7(1):71. PubMed ID: 37488222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances of pathomics in colorectal cancer diagnosis and prognosis.
    Wu Y; Li Y; Xiong X; Liu X; Lin B; Xu B
    Front Oncol; 2023; 13():1094869. PubMed ID: 37538112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting MDM2 in Soft-Tissue Sarcomas (and Other Solid Tumors): The Revival?
    Italiano A
    Cancer Discov; 2023 Aug; 13(8):1765-1767. PubMed ID: 37539475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HER3 targeting augments the efficacy of panobinostat in claudin-low triple-negative breast cancer cells.
    Lyu H; Hou D; Liu H; Ruan S; Tan C; Wu J; Hicks C; Liu B
    NPJ Precis Oncol; 2023 Aug; 7(1):72. PubMed ID: 37537339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep learning-based diagnosis of histopathological patterns for invasive non-mucinous lung adenocarcinoma using semantic segmentation.
    Zhao Y; He S; Zhao D; Ju M; Zhen C; Dong Y; Zhang C; Wang L; Wang S; Che N
    BMJ Open; 2023 Jul; 13(7):e069181. PubMed ID: 37491086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathological Images Analysis and Predictive Modeling Implemented in Digital Pathology-Current Affairs and Perspectives.
    Moscalu M; Moscalu R; Dascălu CG; Țarcă V; Cojocaru E; Costin IM; Țarcă E; Șerban IL
    Diagnostics (Basel); 2023 Jul; 13(14):. PubMed ID: 37510122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologically Based Pharmacokinetic Modelling to Predict Imatinib Exposures in Cancer Patients with Renal Dysfunction: A Case Study.
    Rowland Yeo K; Hatley O; Small BG; Johnson TN
    Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and Safety of P2Y12 Inhibitor Pretreatment for Primary PCI in STEMI: Systematic Review and Meta-analysis.
    Presume J; Gomes DA; Ferreira J; Albuquerque F; Almeida M; Uva MS; Aguiar C; Mendes M
    J Cardiovasc Pharmacol; 2023 Oct; 82(4):298-307. PubMed ID: 37506674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologics and Hypereosinophilic Syndromes: Knowledge Gaps and Controversies.
    Kuang FL; Khoury P; Weller PF; Wechsler ME; Klion AD
    J Allergy Clin Immunol Pract; 2023 Sep; 11(9):2666-2671. PubMed ID: 37507068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tizanidine Induced Hypotension: Report of a Case and Review of the Literature.
    Mahajan R; Kalita J
    Curr Drug Saf; 2024; 19(2):313-316. PubMed ID: 37489780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. After 3 months of medication balloon therapy, a patient who had contrast-induced encephalopathy recovered: A case report.
    Kong K; Chen A; Yang G; Gao R; Zhang S; Liu L; Chen X
    Medicine (Baltimore); 2023 Jul; 102(30):e34392. PubMed ID: 37505152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case report of Trousseau syndrome.
    Liu XJ; Liu YX; Zhang NY
    Medicine (Baltimore); 2023 Jul; 102(30):e34449. PubMed ID: 37505132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of Paper-Based Microfluidic Analytical Devices (µPAD) in Forensic and Clinical Toxicology: A Review.
    Musile G; Grazioli C; Fornasaro S; Dossi N; De Palo EF; Tagliaro F; Bortolotti F
    Biosensors (Basel); 2023 Jul; 13(7):. PubMed ID: 37504142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin and clopidogrel resistance; a neglected gap in stroke and cardiovascular practice in Iran: a systematic review and meta-analysis.
    Parsa-Kondelaji M; Mansouritorghabeh H
    Thromb J; 2023 Jul; 21(1):79. PubMed ID: 37501091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative deep learning analysis improves colon adenocarcinoma patient stratification at risk for mortality.
    Zhou J; Foroughi Pour A; Deirawan H; Daaboul F; Aung TN; Beydoun R; Ahmed FS; Chuang JH
    EBioMedicine; 2023 Aug; 94():104726. PubMed ID: 37499603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I/IB trial of binimetinib in combination with erlotinib in NSCLC harboring activating KRAS or EGFR mutations.
    Saltos AN; Creelan BC; Tanvetyanon T; Chiappori AA; Antonia SJ; Shafique MR; Ugrenovic-Petrovic M; Sansil S; Neuger A; Ozakinci H; Boyle TA; Kim J; Haura EB; Gray JE
    Lung Cancer; 2023 Sep; 183():107313. PubMed ID: 37499521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Titin as a potential novel therapeutic target in colorectal cancer.
    Wei H; Ren K; Zhang Q; Jin Y; Cao B; Tian Z; Mao T; Ren L
    J Cell Mol Med; 2023 Oct; 27(19):2937-2944. PubMed ID: 37499109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidized dietary lipids induce vascular inflammation and atherogenesis in post-menopausal rats: estradiol and selected antihyperlipidemic drugs restore vascular health in vivo.
    Folahan JT; Olorundare OE; Ajayi AM; Oyewopo AO; Soyemi SS; Adeneye AA; Okoye II; Afolabi SO; Njan AA
    Lipids Health Dis; 2023 Jul; 22(1):107. PubMed ID: 37495992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination Lipid-Lowering Therapy in Patients Undergoing Percutaneous Coronary Intervention.
    Lee SJ; Joo JH; Park S; Kim C; Choi DW; Hong SJ; Ahn CM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Nam CM; Hong MK
    J Am Coll Cardiol; 2023 Aug; 82(5):401-410. PubMed ID: 37495276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteolysis-Targeting Chimeras (PROTACs) targeting the BCR-ABL for the treatment of chronic myeloid leukemia - a patent review.
    Vicente ATS; Salvador JAR
    Expert Opin Ther Pat; 2023; 33(6):397-420. PubMed ID: 37494069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.